79 related articles for article (PubMed ID: 8868945)
1. [Carboplatin and cyclophosphamide in stage Ic-IV ovarian carcinoma: retrospective study of 101 cases].
Petit T; Dufour P; Barrats JC; Maloisel F; Duclos B; Giron C; Lioure B; Dellenbach P; Renaud R; Ritter J; Audhuy B; Bergerat JP; Oberling F
Bull Cancer; 1996 Jul; 83(7):566-72. PubMed ID: 8868945
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: a phase I trial.
Fennelly D; Wasserheit C; Schneider J; Hakes T; Reich L; Curtin J; Yao TJ; Markman M; Norton L; Crown J
Cancer Res; 1994 Dec; 54(23):6137-42. PubMed ID: 7525055
[TBL] [Abstract][Full Text] [Related]
3. High-dose platinum versus standard dose in advanced ovarian carcinoma: a randomized trial from the Gynecologic Cooperative Group of the French Comprehensive Cancer Centers (FNCLCC).
Joly F; Héron JF; Kerbrat P; Chauvergne J; Rios M; Mayer F; Chinet-Charrot P; Goupil A; Lebrun-Jezekova D; Vennin D; Lhommé C; Macé-Lesec'h J; Crouet H
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):361-8. PubMed ID: 10985895
[TBL] [Abstract][Full Text] [Related]
4. Intensive sequential dose dense chemotherapy with stem cell support as first-line treatment in advanced ovarian carcinoma: a phase II study.
Viret F; Bertucci F; Genre D; Gravis G; Chabannon C; Conte M; Houvenaeghel G; Maraninchi D; Viens P
Bone Marrow Transplant; 2002 Dec; 30(12):879-84. PubMed ID: 12476280
[TBL] [Abstract][Full Text] [Related]
5. [Maintenance of the dose-intensity of chemotherapy combining carboplatin, cyclophosphamide, etoposide in women with ovarian cancer aged 70 and over].
Delva R; Mege M; Gamelin E; Maillart P; Lortholary A; Guérin O; Pein F; Larra F
Bull Cancer; 1996 Jan; 83(1):63-69. PubMed ID: 8672858
[TBL] [Abstract][Full Text] [Related]
6. Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.
Bamias A; Papadimitriou C; Efstathiou E; Rodolakis A; Vlahos G; Voulgaris Z; Bozas G; Fountzilas G; Aravantinos G; Razis E; Gika D; Dimopoulos MA
BMC Cancer; 2006 Sep; 6():228. PubMed ID: 16999858
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic strategy in the management of stage II-IV epithelial ovarian carcinoma.
Sun T; Feng Y; Zhu Y; Zheng Y
Chin Med J (Engl); 2000 Jul; 113(7):625-7. PubMed ID: 11776033
[TBL] [Abstract][Full Text] [Related]
8. Dose escalation combination carboplatin/cyclophosphamide chemotherapy for epithelial ovarian cancer.
Smith HO; Goldberg GL; Carol L; Davidson SA; Tomaino C; Centrilla L; Runowicz CD
Eur J Gynaecol Oncol; 1994; 15(6):411-7. PubMed ID: 7875155
[TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic factors in advanced epithelial ovarian carcinoma.
Chi DS; Liao JB; Leon LF; Venkatraman ES; Hensley ML; Bhaskaran D; Hoskins WJ
Gynecol Oncol; 2001 Sep; 82(3):532-7. PubMed ID: 11520151
[TBL] [Abstract][Full Text] [Related]
10. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
[TBL] [Abstract][Full Text] [Related]
11. Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer.
Alberts DS; Green S; Hannigan EV; O'Toole R; Stock-Novack D; Anderson P; Surwit EA; Malvlya VK; Nahhas WA; Jolles CJ
J Clin Oncol; 1992 May; 10(5):706-17. PubMed ID: 1569443
[TBL] [Abstract][Full Text] [Related]
12. Phase I and pharmacologic study of the combination paclitaxel and carboplatin as first-line chemotherapy in stage III and IV ovarian cancer.
Huizing MT; van Warmerdam LJ; Rosing H; Schaefers MC; Lai A; Helmerhorst TJ; Veenhof CH; Birkhofer MJ; Rodenhuis S; Beijnen JH; ten Bokkel Huinink WW
J Clin Oncol; 1997 May; 15(5):1953-64. PubMed ID: 9164207
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
Skarlos DV; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos GP; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer.
Aghajanian C; Fennelly D; Shapiro F; Waltzman R; Almadrones L; O'Flaherty C; O'Conner K; Venkatraman E; Barakat R; Curtin J; Brown C; Reich L; Wuest D; Norton L; Hoskins W; Spriggs DR
J Clin Oncol; 1998 May; 16(5):1852-60. PubMed ID: 9586901
[TBL] [Abstract][Full Text] [Related]
15. Pilot study of cyclophosphamide plus carboplatin in advanced ovarian carcinoma.
Edmonson JH; McCormack GW; Krook JE; Long HJ; Jefferies JA; Richardson RL
Cancer Treat Rep; 1987 Feb; 71(2):199-200. PubMed ID: 3542210
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of topotecan and cisplatin as first line chemotherapy in epithelial ovarian cancer].
Meng LH; Kong BH; Zhang YZ; Yang XS; Wang LJ; Su SL; Jiang J; Cui BX; Wang B
Zhonghua Fu Chan Ke Za Zhi; 2007 Oct; 42(10):683-7. PubMed ID: 18241544
[TBL] [Abstract][Full Text] [Related]
17. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
Bertucci F; Viens P; Delpero JR; Bardou VJ; Faucher C; Houvenaeghel G; Maraninchi D
Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406
[TBL] [Abstract][Full Text] [Related]
18. Drug sensitivity-related benefit of systematic lymphadenectomy during cytoreductive surgery in optimally debulked stages IIIc and IV ovarian cancer.
Isonishi S; Niimi S; Sasaki H; Ochiai K; Yasuda M; Tanaka T
Gynecol Oncol; 2004 Jun; 93(3):647-52. PubMed ID: 15196859
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group.
Swenerton K; Jeffrey J; Stuart G; Roy M; Krepart G; Carmichael J; Drouin P; Stanimir R; O'Connell G; MacLean G
J Clin Oncol; 1992 May; 10(5):718-26. PubMed ID: 1569444
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of intraperitoneal carboplatin versus intravenous carboplatin with intravenous cyclophosphamide in both arms as initial chemotherapy for stage III ovarian cancer.
Polyzos A; Tsavaris N; Kosmas C; Giannikos L; Katsikas M; Kalahanis N; Karatzas G; Christodoulou K; Giannakopoulos K; Stamatiadis D; Katsilambros N
Oncology; 1999; 56(4):291-6. PubMed ID: 10343192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
